TXT
70
-2
FITB
65
2
CA
15
6
UNP
50
2
DOW
62
2
HPQ
37
6
DG
57
7
ACN
22
6
ESS
33
2
IBM
67
3
FE
62
2
HSY
53
3
FOX
26
-2
KR
49
4
PG
20
-2
XYL
33
-2
ORLY
58
8
CNP
70
2
CINF
58
3
RRC
70
12
TXT
70
-2
FITB
65
2
CA
15
6
UNP
50
2
DOW
62
2
HPQ
37
6
DG
57
7
ACN
22
6
ESS
33
2
IBM
67
3
FE
62
2
HSY
53
3
FOX
26
-2
KR
49
4
PG
20
-2
XYL
33
-2
ORLY
58
8
CNP
70
2
CINF
58
3
RRC
70
12
Financhill
Back

First Trust S&P 500 Diversified Dv Aristocrats ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
54

KNGZ
First Trust S&P 500 Diversified Dv Aristocrats ETF

Last Price:
$35.88
Seasonality Move:
3.37%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
54
First Trust S&P 500 Diversified Dv Aristocrats ETF (KNGZ) is a Buy

Is First Trust S&P 500 Diversified Dv Aristocrats ETF a Buy, Sell or Hold?

  • The current First Trust S&P 500 Diversified Dv Aristocrats ETF [KNGZ] share price is $36.14. The Score for KNGZ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • KNGZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

KNGZ Stock Price Chart

What is First Trust S&P 500 Diversified Dv Aristocrats ETF's stock price today?

  • The First Trust S&P 500 Diversified Dv Aristocrats ETF share price today is $36.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNGZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

KNGZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 46.22 Sell
Chaikin Money Flow: 871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.59 - 37.29) Sell
Bollinger Bands (100): (35.39 - 37.77) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

KNGZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.9 Buy
20-day SMA: 36.07 Buy
50-day SMA: 37.23 Sell
200-day SMA: 35.7 Buy
8-day EMA: 35.93 Buy
20-day EMA: 36.22 Sell
50-day EMA: 36.68 Sell
200-day EMA: 35.71 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

First Trust S&P 500 Diversified Dv Aristocrats ETF Earnings Growth & KNGZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

First Trust S&P 500 Diversified Dv Aristocrats ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):